Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07794644 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Neonatal Hip Screening With Artificial Intelligence

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Feb 2027 → Jun 2027
See other at-risk trials from Murdoch Childrens Research Institute

Record History

  1. Start date pushed from Aug 2026 to Dec 2026 Primary completion pushed from Feb 2027 to Jun 2027 · Completion pushed from Mar 2027 to Jun 2027 Show 2 more changesShow less
    • Primary completion pushed from Feb 2027 to Jun 2027
    • Completion pushed from Mar 2027 to Jun 2027
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this trial is to pilot a portable ultrasound device that uses artificial intelligence to screen for hip dysplasia. Researchers will gather data to understand the feasibility of performing a larger trial in birthing hospitals. It will also seek to collect initial data on how well the scan compares to the standard hip screening performed soon after birth. Participants will: * Have the portable ultrasound performed on their baby before they are discharged from hospital * Have a diagnostic ultrasound performed on their baby at 6-weeks of age * Complete a short questionnaire about the experience of having the measurement performed on their baby
Trial Details
NCT Number NCT07794644
Lead Sponsor Murdoch Childrens Research Institute
Collaborators: Monash Health, University of Alberta
Conditions Developmental Dysplasia of Hip
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov